- Home
- NRIX vs STAA Comparison
NRIX vs STAA Comparison
Compare NRIX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | STAA |
|---|---|---|
| Founded | 2009 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 867.9M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NRIX | STAA |
|---|---|---|
| Price | $15.47 | $19.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | ★ $30.58 | $22.19 |
| AVG Volume (30 Days) | 968.3K | ★ 1.1M |
| Earning Date | 04-10-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $76,987,000.00 | ★ $239,442,000.00 |
| Revenue This Year | N/A | $27.04 |
| Revenue Next Year | $26.32 | $7.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.18 | $14.69 |
| 52 Week High | $22.50 | $30.81 |
Technical Indicators
Market Signals| Indicator | NRIX | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 55.22 |
| Support Level | $14.61 | $16.60 |
| Resistance Level | $16.47 | $19.41 |
| Average True Range (ATR) | 0.89 | 1.02 |
| MACD | 0.10 | 0.12 |
| Stochastic Oscillator | 66.06 | 96.05 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.